PER 2.47% 7.9¢ percheron therapeutics limited

Chart, page-1981

  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    If you go over the presentations and interviews in the last 6 months, funding intention can't be any more clearer.

    ANP is looking at partnership / licensing approach to get us through P2B in Europe.

    Moses and Diamond will need to go if they can't achieve strategic funding.

    Maybe as a good will gesture there may be a small SPP at same time so existing investors?

    AEF hopefully are out of the picture.u
    Last edited by Uboy: 20/07/20
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.